drugset / Trial / NCT03125057
A Pilot Study of Hemoporfin PDT in Children With Port-wine Stain
Non-randomizedSequentialSingle-blindTreatment
Summary
This pilot study aims to evaluate the efficacy and safety of hemoporfin photodynamic therapy (PDT) with different light doses for port-wine stain (PWS） in 7-14 years old children. The population pharmacokinetics of hemoporfin in children will be investigated as well.
Timeline
- Start
- 2017-08-02
- Primary completion
- 2020-05-10
- Completion
- 2020-05-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hematoporphyrin | Small molecule | 5 mg/kg | Intravenous |
Indications
No indication recorded.